Peripheral IV Catheter Market to Surpass USD 16.38 Billion by 2032, Driven by Rising Hospital Admissions and Advanced Healthcare Infrastructure

Market Overview and Growth Insights

The global Peripheral Intravenous (IV) Catheter Market has witnessed robust growth over the past decade, propelled by an upsurge in chronic diseases, technological advancements in catheterization techniques, and expanding hospital infrastructure worldwide. Valued at US$ 5,728.00 million in 2025, the market is projected to attain a valuation of US$ 16,385.00 million by 2032, growing at an impressive CAGR of 16.2% during the forecast period. This significant market expansion can be attributed to the rising demand for safe and effective intravenous drug delivery systems, increasing surgical procedures, and growing global healthcare expenditure.

Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/3324

Among product segments, short peripheral IV catheters dominate the market with a 66.4% share in 2024, primarily due to their versatility and ease of use across multiple treatment settings, including chemotherapy, anesthesia, and emergency care. Regionally, North America leads the market, driven by advanced healthcare systems, favorable reimbursement policies, and a high incidence of chronic diseases. The United States alone accounted for approximately 36.2% of the North American market in 2024, further underscoring its leadership in adoption and innovation.

✦ Key Highlights from the Report

✦ Global market expected to grow at a CAGR of 16.2% between 2025 and 2032
✦ Short peripheral IV catheter segment holds 66.4% market share as of 2024
✦ United States contributes over 36% of the North American market revenue
✦ Germany benefits from national PVC infection prevention guidelines
✦ Growing demand for integrated catheters drives new product development
✦ Shockwave Medical's M5+ IVL catheter received FDA & CE mark approval in 2022

Market Segmentation

The Peripheral IV Catheter Market is segmented by product type, technology, and end-user.

By product type, the market is categorized into short peripheral IV catheters and integrated/closed IV catheters. Short peripheral IV catheters dominate due to their broad applicability, especially in chemotherapy, critical care, and emergency services. Integrated catheters, while still emerging, are growing rapidly due to their reduced risk of infection and better user experience.

In terms of technology, demand is fueled by innovations such as pressure-reducing catheter designs and antimicrobial coatings. Advanced materials and integrated safety mechanisms are helping prevent needle-stick injuries and reduce complications like phlebitis or occlusion.

Regarding end-users, hospitals remain the primary consumer due to high inpatient volumes and constant demand for intravenous therapies. Ambulatory surgical centers and clinics are growing contributors, with increased outpatient treatments and preference for less invasive solutions.

Regional Insights

In North America, particularly the U.S., the market is booming due to the high incidence of chronic illnesses like cardiovascular disorders, coupled with the increasing cases of needlestick injuries. Strong regulatory infrastructure, insurance coverage, and healthcare awareness are pivotal factors contributing to the region's dominance.

Europe holds a significant share, with Germany emerging as a prominent market, largely due to national PVC infection prevention guidelines and an increase in hospital admissions. The availability of trained healthcare personnel and standardization in catheter use are critical contributors.

Asia-Pacific, especially Japan, is experiencing rapid market growth. The aging population, increasing prevalence of chronic diseases, and growing investment in healthcare infrastructure have positioned Japan as a key player in the global landscape. Local manufacturing and affordability are other growth factors driving demand.

Meanwhile, emerging economies in Latin America and the Middle East & Africa are slowly catching up, fueled by improving medical infrastructure and rising healthcare investments. However, awareness and affordability remain constraints in these regions.

Market Drivers

A key market driver is the increasing prevalence of chronic diseases such as diabetes, cancer, and cardiovascular conditions. These conditions often require long-term intravenous treatment, making peripheral IV catheters essential. Another major driver is the technological innovation in catheter design, such as the advent of integrated catheters that reduce risks of contamination, minimize patient discomfort, and improve clinical outcomes. Moreover, the increasing number of hospitalizations and a shift toward minimally invasive treatments have amplified the need for reliable venous access devices.

Market Restraints

Despite promising growth, the market faces several challenges. One major restraint is the lack of trained healthcare professionals for safe catheter insertion and maintenance. Improper handling can lead to hospital-acquired infections (HAIs), limiting the adoption of these devices in under-resourced regions. Another restraint is the high cost associated with advanced catheter systems, which restricts their usage in low and middle-income countries. Additionally, painful insertion procedures and risk of phlebitis may discourage both patients and practitioners from frequent use.

Market Opportunities

As healthcare shifts towards value-based care, the demand for advanced, risk-free, and cost-effective catheter solutions is expected to rise. The increasing acceptance of closed/integrated PIVCs, which reduce infection rates and improve patient outcomes, presents a significant opportunity for manufacturers. There's also untapped growth potential in emerging economies, where improving healthcare infrastructure and rising awareness can drive adoption. Moreover, the increased use of catheters for home healthcare and outpatient services creates further avenues for expansion.

# Frequently Asked Questions (FAQs)

How Big is the Peripheral IV Catheter Market?
Who are the Key Players in the Global Peripheral IV Catheter Market?
What is the Projected Growth Rate of the Peripheral IV Catheter Market?
What is the Market Forecast for Peripheral IV Catheter Market for 2032?
Which Region is Estimated to Dominate the Industry through the Forecast Period?

Company Insights

• B. Braun Melsungen AG
• Becton, Dickinson and Company (BD)
• Terumo Corporation
• Smiths Medical (ICU Medical, Inc.)
• Vygon SA
• Teleflex Incorporated
• Medline Industries Inc.
• Nipro Medical Corporation
• Argon Medical Devices
• Shanghai Puyi Medical Instruments Co., Ltd.

Recent Developments:

• B. Braun Medical Inc., on September 22, 2022, acquired Starboard Medical, Inc., boosting its catheter securement product offerings with Clik-FIX devices.
• Shockwave Medical, Inc. launched its Shockwave M5+ peripheral IVL catheter globally on March 31, 2022, following FDA and CE mark clearance, enhancing global access to cutting-edge peripheral IVL technology.

Conclusion

The Peripheral IV Catheter Market is positioned for transformative growth, with the global valuation expected to triple by 2032. Backed by a surge in chronic conditions, technological advancements in catheter design, and the growing need for minimally invasive drug delivery systems, the market presents a fertile ground for innovation and investment. Despite certain limitations such as cost and training gaps, evolving product designs, especially the integrated/closed PIVCs, are paving the way for safer and more efficient vascular access. Companies that prioritize R&D and adapt to the regional healthcare dynamics will be well-positioned to thrive in this burgeoning market.

Persistence Market Research
G04 Golden Mile House, Clayponds Lane
Brentford, London, TW8 0GU UK
USA Phone: +1 646-878-6329
UK Phone: +44 203-837-5656
Email: sales@persistencemarketresearch.com
Web:
https://www.persistencemarketresearch.com

About Persistence Market Research:

At Persistence Market Research, we specialize in creating research studies that serve as strategic tools for driving business growth. Established as a proprietary firm in 2012, we have evolved into a registered company in England and Wales in 2023 under the name Persistence Research & Consultancy Services Ltd. With a solid foundation, we have completed over 3600 custom and syndicate market research projects, and delivered more than 2700 projects for other leading market research companies' clients.

Our approach combines traditional market research methods with modern tools to offer comprehensive research solutions. With a decade of experience, we pride ourselves on deriving actionable insights from data to help businesses stay ahead of the competition. Our client base spans multinational corporations, leading consulting firms, investment funds, and government departments. A significant portion of our sales comes from repeat clients, a testament to the value and trust we've built over the years.

This release was published on openPR.